Literature DB >> 26648431

The relationship between genotype, psychiatric symptoms and quality of life in adult patients with sickle cell disease in São Paulo, Brazil: a cross-sectional study.

Érika Bergamini Mastandréa1, Fátima Lucchesi1, Marcela Mayumi Gomes Kitayama1, Maria Stella Figueiredo2, Vanessa de Albuquerque Citero1.   

Abstract

CONTEXT AND
OBJECTIVE: Health-related quality of life (HRQoL) may be worsened in sickle cell patients due to the presence of psychiatric disorders. The aims of this study were to describe the psychiatric symptoms in Brazilian sickle cell patients and to evaluate the relationship of these symptoms to the genotype of the disease and the subject's HRQoL. DESIGN AND
SETTING: Cross-sectional study conducted at the hematology outpatient clinic, Hospital São Paulo.
METHODS: Adult patients with sickle cell disease completed the Medical Outcome Study - Short Form 36 and the Patients' Health Questionnaire. Clinical data were gathered from their medical files. Linear regression models were developed to study the dependency of HRQoL domains on the genotype controlling for psychiatric symptoms.
RESULTS: In the study period, 110 patients were evaluated. The most frequent psychiatric symptom was depression (30%), followed by anxiety (12.7%) and alcohol abuse (9.1%). Patients with the more severe genotype (SS and Sβthal0) showed lower scores for the "general health" and "role-physical" HRQoL domains, without interference from psychiatric symptoms. In the "role-physical" domain, the more severe genotype operated as a protective factor for HRQoL (β = 0.255; P = 0.007).
CONCLUSION: The more severe genotypes worsened HRQoL in two domains of physical health (general health and role-physical), but they did not have any influence on mental health, thus suggesting that physicians should be more attentive to aspects of HRQoL relating to the functionality of sickle cell disease patients, so as to be aware of the limitations that these patient live with.

Entities:  

Mesh:

Year:  2015        PMID: 26648431     DOI: 10.1590/1516-3180.2015.00171105

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  6 in total

1.  Depression, quality of life, and medical resource utilization in sickle cell disease.

Authors:  Soheir S Adam; Charlene M Flahiff; Shital Kamble; Marilyn J Telen; Shelby D Reed; Laura M De Castro
Journal:  Blood Adv       Date:  2017-10-12

Review 2.  Optimizing the management of chronic pain in sickle cell disease.

Authors:  Ifeyinwa Osunkwo; Hazel F O'Connor; Elna Saah
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

3.  A pilot test of the Adult Sickle Cell Quality of Life Measurement Information System (ASCQ-Me) and the Jenerette Self-Care Assessment (J-SAT) Tools in adults with sickle cell disease.

Authors:  Dominique Bulgin; Christian Douglas; Paula Tanabe
Journal:  Pilot Feasibility Stud       Date:  2019-07-04

4.  Preference-based measure of health-related quality of life and its determinants in sickle cell disease in Nigeria.

Authors:  Adedokun Oluwafemi Ojelabi; Afolabi Elijah Bamgboye; Jonathan Ling
Journal:  PLoS One       Date:  2019-11-18       Impact factor: 3.240

5.  Estimated Life Expectancy and Income of Patients With Sickle Cell Disease Compared With Those Without Sickle Cell Disease.

Authors:  Deborah Lubeck; Irene Agodoa; Nickhill Bhakta; Mark Danese; Kartik Pappu; Robin Howard; Michelle Gleeson; Marc Halperin; Sophie Lanzkron
Journal:  JAMA Netw Open       Date:  2019-11-01

6.  Descriptive analysis of sickle cell patients living in France: The PHEDRE cross-sectional study.

Authors:  Marie Gerardin; Morgane Rousselet; Marie-Laure Couec; Agathe Masseau; Marylène Guerlais; Nicolas Authier; Sylvie Deheul; Anne Roussin; Joelle Micallef; Samira Djezzar; Fanny Feuillet; Pascale Jolliet; Caroline Victorri-Vigneau
Journal:  PLoS One       Date:  2021-03-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.